Lipopolysaccharide antigen (LPS antigen)

The **lipopolysaccharide antigen** refers primarily to the highly variable *O-specific polysaccharide* ("O-antigen") portion found on lipopolysaccharides—major components on the outer membrane surface of Gram-negative bacteria. The full lipopolysaccharide molecule consists of three parts: lipid A (the endotoxic anchor), a core oligosaccharide, and an outward-facing chain called the O-antigen. The structure and composition of this polysaccharide chain vary greatly between species and even strains; these differences form the basis for serotyping Gram-negative pathogens such as *Escherichia coli* and *Salmonella*. The presence and structure of specific lipopolysaccharide antigens determine how bacteria interact with host immune systems—triggering strong innate responses via pattern recognition receptors like TLR4/CD14/MD2—and play critical roles in both pathogenesis (by helping evade complement-mediated killing) and immunity. Because it is exposed on bacterial surfaces, it serves as both a key virulence factor for pathogens and an important target for vaccines, diagnostics, monoclonal antibody therapies, and experimental anti-endotoxin treatments. However, its extreme variability poses challenges for broad-spectrum interventions.

Other names

Lipopolysaccharide O-antigenLPS O-antigenO-specific polysaccharideO-polysaccharide (O-PS)Endotoxin antigen

Binding to lipid A or polysaccharide regions to neutralize endotoxin activity or block interaction with host receptors such as TLR4/CD14/MD2 complex. Monoclonal antibodies may block immune recognition or promote opsonization for clearance. Vaccines using modified/synthetic LPS antigens induce protective immunity by generating specific antibodies against pathogenic bacteria's surface antigens.